News | February 09, 2015

Medtronic Introduces New Valve Sizes for CoreValve Evolut R System

Self-expanding TAVI valve gains CE Mark approval for 26, 29 mm versions

Corevalve, valve sizes

February 9, 2015 — Medtronic announced CE (Conformité Européene) mark for the 26 and 29 mm sizes of the CoreValve Evolut R System, a next-generation self-expanding valve for transcatheter aortic valve implantation (TAVI) providing the option to recapture and reposition the valve during procedures. The new larger valve sizes are delivered through a 14 French equivalent delivery system allowing small vessels to be accessed, and offer an extended sealing skirt intended to further promote valve sealing at the annulus.

The 23, 26 and 29 mm sizes of the CoreValve Evolut R and the CoreValve EnVeo R Delivery Catheter System are available in Europe and other countries that recognize the CE mark. It is not approved for commercial use in the United States, where it is currently undergoing clinical trials.

“The clinical experience with the Evolut R system has been exceptional. The system’s optimal positioning and delivery of the valve are essential to achieve the very best clinical results in TAVI. Evolut R’s low profile, positioning accuracy and enhanced sealing, all supported with the option to recapture and reposition during implantation, are a significant advance for transcatheter therapy,” said Ganesh Manoharan, M.D., consultant cardiologist, Royal Victoria Hospital, co-lead for the CoreValve Evolut R CE mark study slated for presentation at the 2015 American College of Cardiology (ACC) annual meeting. “Expanding the Evolut R valve size range enables physicians to bring these important advances to a much broader range of patients.”

The system is designed for first-time positioning accuracy and also offers an InLine Sheath that significantly reduces the profile to a 14 French equivalent, less than 1/5 inch; a smaller profile size provides a greater opportunity to treat patients with smaller vessels (down to 5 mm), which may minimize the risk of major vascular complications in some patients. The Evolut R valve is also anatomically designed for optimal fit and sealing, while maintaining strong hemodynamic performance.

For more information: www.medtronic.com


Related Content

News | Heart Valve Technology

June 29, 2026 — Laplace Interventional recently announced that the U.S. Food and Drug Administration (FDA) has approved ...

Home July 02, 2026
Home
Feature | Heart Valve Technology | Kyle Hardner

Primary care providers (PCPs) stand on the front lines of diagnosing clinically significant valvular heart disease (VHD) ...

Home July 01, 2026
Home
News | Heart Valve Technology

June 29, 2026 — Konica Minolta, Inc. has announced that a research group has developed a simple and rapid technique for ...

Home June 29, 2026
Home
News | Heart Valve Technology

June 18, 2026 — Nyra Medical has been selected as the recipient of the 2026 Jon DeHaan Foundation Award for ...

Home June 19, 2026
Home
News | Heart Valve Technology

April 24, 2026 – A novel detection algorithm spotted moderate-to-severe aortic stenosis (AS) with a sensitivity of 90.5% ...

Home April 24, 2026
Home
News | Heart Valve Technology

April 21, 2026 — A new multicenter study published in The Annals of Thoracic Surgery finds that reoperative surgical ...

Home April 22, 2026
Home
News | Heart Valve Technology

Dec. 26, 2025 — Edwards Lifesciences has announced the company’s SAPIEN M3 mitral valve replacement system, a ...

Home December 24, 2025
Home
News | Heart Valve Technology

Nov. 17, 2025 — Royal Philips has introduced DeviceGuide, an AI-powered device tracking* solution that assists ...

Home November 17, 2025
Home
News | Heart Valve Technology | Cedars-Sinai Medical Center

Oct. 28, 2025 — People who underwent a minimally invasive procedure to have their heart’s aortic valve replaced had ...

Home October 29, 2025
Home
News | Heart Valve Technology

Aug. 28, 2025 — Medtronic plc has announced it received U.S. Food and Drug Administration (FDA) approval for the ...

Home August 29, 2025
Home
Subscribe Now